info@doclabinc.com

(503) 402-2504

STI Panel PCR Testing

Sexually transmitted infections require confident diagnosis and timely treatment. Our STI Panel uses PCR-based molecular testing to detect common STI pathogens with precision—delivering results during the patient visit, not days later.

Accurate STI Diagnosis Matters

Sexually transmitted infections are common, treatable, and too often missed or delayed in diagnosis. Traditional testing methods can mean sending specimens to outside labs, waiting days for results, and requiring patient callbacks to initiate treatment.

That delay has consequences. Continued transmission. Patient anxiety. Lost follow-up when patients don’t return for results. Treatment initiation that happens days after it should.

PCR-based molecular testing changes this dynamic. Highly accurate pathogen detection, delivered in your office, with results that enable same-visit clinical decisions. Diagnose with confidence. Treat promptly. Reduce transmission.

How the STI Panel Works

The STI Panel uses polymerase chain reaction (PCR) technology to detect pathogen DNA directly from patient specimens. Unlike culture-based methods or less sensitive tests, PCR provides molecular-level precision for accurate pathogen identification.

Specimen collection follows standard protocols for STI testing. Specimens are processed through your POL’s PCR system, with results available during the patient visit or shortly thereafter. Clear pathogen identification supports confident diagnosis and appropriate treatment selection.

The result is STI testing that fits your practice workflow—accurate, efficient, and designed for in-office use.

Key Benefits

R

Molecular Precision

PCR-based detection provides highly accurate pathogen identification. Confident diagnosis, appropriate treatment.

R

Same-Day Results

Results the same day enable timely treatment decisions. No waiting days for outside lab results.

R

Comprehensive Panel

Tests for common STI pathogens in a single panel. Broad coverage from one specimen.

R

Reduce Send-Outs

Keep STI testing in your practice instead of relying on reference laboratories. Better turnaround, better patient experience.

R

Enable Prompt Treatment

Faster diagnosis means faster treatment initiation. Better patient outcomes, reduced transmission risk.

R

Support Sensitive Conversations

Having results during the visit supports the clinical conversation—patients leave with answers and a treatment plan.

Sample Report

Sample STI Panel report showing pathogen identification results. Clear presentation supports confident diagnosis and treatment decisions.

Who Should Consider the STI Panel

R

Urology Practices

STI testing is often part of urological care. In-office PCR testing enables efficient diagnosis without send-out delays.

R

OB/GYN Practices

STI screening is routine in women's health. Same-visit results support timely treatment and patient counseling.

R

Primary Care Practices

STI is among the most common diagnoses in primary care. In-office molecular testing streamlines the diagnostic process.

R

Urgent Care Centers

Patients with STI symptoms expect rapid answers. PCR-based testing delivers the accuracy and speed urgent care demands.

R

Multi-Specialty Clinics

For organizations serving diverse patient populations, the STI Panel adds valuable diagnostic capability to your POL.

Common Questions

What pathogens does the STI Panel detect?

The STI Panel detects common sexually transmitted pathogens including Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, Ureaplasma urealyticum, and HSV1/HSV2.

How long does it take to get results?

Results are available the same day—same-day turnaround for in-office PCR testing.

Can I run the STI Panel in my POL?

Yes. The STI Panel is designed for physician office laboratories with Doc Lab's implementation and support.

Is the STI Panel appropriate for asymptomatic screening?

Yes. PCR-based testing is appropriate for both symptomatic diagnosis and asymptomatic screening as indicated by clinical guidelines.